Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01167361
Other study ID # XPD10-082 RESVPI
Secondary ID
Status Completed
Phase N/A
First received July 20, 2010
Last updated October 30, 2012
Start date September 2010
Est. completion date October 2011

Study information

Verified date July 2011
Source St. Jude Children's Research Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This study aims to prospectively estimate the incidence of Respiratory virus (RV) infections in children with symptoms of an upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI) at St. Jude Children's Research Hospital (SJCRH) using the FilmArrayTM System, a novel highly sensitive and rapid assay for RV detection. An aliquot from the leftover sample remaining after clinical diagnostic testing will be used for FilmArrayTM analysis. Patients will be accrued on the study over a one year period.


Description:

The Primary Objective of the study is:

- Prospectively estimate the incidence of Respiratory virus (RV) infections in children with symptoms of an upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI) at St. Jude Children's Research Hospital(SJCRH).

The Secondary Objectives of the study are:

- Study the association between RV infections and clinical variables.

- Prospectively estimate the duration of RV infections in symptomatic children at SJCRH.

- Compare the sensitivity and specificity of the current molecular method of analysis of respiratory viruses with the FilmArrayTM method.


Recruitment information / eligibility

Status Completed
Enrollment 350
Est. completion date October 2011
Est. primary completion date October 2011
Accepts healthy volunteers No
Gender Both
Age group N/A to 18 Years
Eligibility Inclusion Criteria:

- Birth to less than or equal to 18 years.

- Patients with an URTI or LRTI undergoing collection of respiratory secretions at SJCRH, by nasopharyngeal wash, nasopharyngeal swab, tracheal aspirate or bronchoalveolar lavage as ordered by the treating physician.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Locations

Country Name City State
United States St . Jude Children's Research Hospital Memphis Tennessee

Sponsors (1)

Lead Sponsor Collaborator
St. Jude Children's Research Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary This study measures the incidence of Respiratory virus (RV) infections in children with symptoms of an upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI) using the FilmArray System This study uses FilmArrayTM System, a novel highly sensitive and rapid assay for respiratory virus infection. An aliquot from the leftover sample remaining after clinical diagnostic testing will be used for FilmArrayTM analysis 1 year No
Secondary Time of first detection of the virus as related to day of transplant, Time of first detection of the virus as related to day of chemotherapy and duration of viral shedding from the time of first detection will all be measured. Different variables will be collected to find the association between Respiratory virus and clinical variables 1 year No
Secondary This study prospectively estimates and measures the duration of Respiratory Virus infections in symptomatic children by studying the epidemiology and natural history of infections with these viruses . These viruses have been known to cause interstitial lung disease, will help clarify the etiology of "idiopathic pneumonia" post chemotherapy . 1 year No
Secondary This study analyses respiratory viruses using Filmarray TM method 1 year No
See also
  Status Clinical Trial Phase
Completed NCT02538770 - Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization N/A
Enrolling by invitation NCT05084898 - Far-UVC Light Devices in Long-term Care Facilities to Reduce Infections N/A
Withdrawn NCT02601365 - Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia Phase 1
Recruiting NCT03816059 - Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications